Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

BCG injection helps reduce long COVID symptoms and affects hair loss differently in men and women.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

The Fas/FasL pathway may play a role in alopecia areata.

GPR40 agonists help hair growth through the protein ANGPTL4.

Hair loss is a common side effect of hormone treatments for cancer.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Improving wogonin's solubility greatly increases its absorption in the body.

Vitamin D levels are not linked to alopecia areata.

Iron and ferritin levels don't affect alopecia areata.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

New treatments using advanced technology aim to improve dry eye disease care.

The red Hibiscus rosa-sinensis flower has the highest antioxidant activity.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

The pandemic highlighted the need for accurate information, vaccine development, and adapting to new routines while managing stress and misinformation.

Three patients suffered severe health issues due to not getting enough vitamins and minerals after weight-loss surgery.

Key genes and pathways, including Wnt, NF-Kappa, and JAK-STAT, are crucial for starting Pashmina fiber growth in goats.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.